Classifying thymomas

Histopathology

Volumn 52, Issue 6, 2008, Pages 759-766

  Addis, B J ^a,c   Den Bakker, M A ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; HUMAN; LYMPHOEPITHELIOMA; NOTE; PRIORITY JOURNAL; THYMOMA; THYMUS CANCER; THYMUS LYMPHOMA; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

HUMANS; THYMOMA; THYMUS NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 42649122281     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03010.x     Document Type: Note

References (51)

1. Rosai J, Levine GD. Tumours of the thymus, 2nd series edn. In Firminger HI ed. Atlas of tumor pathology, vol. 13. Washington, DC: Armed Forces Institute of Pathology, 1976.
2. Legg MA, Brady WJ. Pathology and clinical behavior of thymomas. A survey of 51 cases. Cancer 1965 18 1131 1144.
3. Friedman NB. Tumors of the thymus. J. Thorac. Cardiovasc. Surg. 1967 53 163 182.
4. Bohm W, Strauch G. Zur Morphologie der epithelialen Thymusgeschwulste. Virchow's Arch 1062 335 632 641.
5. Snover DC, Levine GD, Rosai J. Thymic carcinoma. Five distinctive histological variants. Am. J. Surg. Pathol. 1982 6 451 470.
6. Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer 1972 29 1061 1074.
7. Lattes R, Jonas S. The pathological and clinical features in eighty cases of thymoma. Bull. N Y Acad. Med. 1957 33 145 147.
8. Lattes R. Thymoma and other tumors of the thymus. An analysis of 107 cases. Cancer 1962 15 1224 1260.
9. Bernatz PE, Harrison EG, Clagett OT. Thymoma: a clinicopathologic study. J. Thorac. Cardiovasc. Surg. 1961 42 424 444.
10. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985 55 1074 1086.
11. Regnard JF, Magdeleinat P, Dromer C et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J. Thorac. Cardiovasc. Surg. 1996 112 376 384.
12. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981 48 2485 2492.
13. Harris NL, Muller-Hermelink HK. Thymoma classification. A siren's song of simplicity. Am. J. Clin. Pathol. 1999 112 299 303.
14. Kornstein MJ. Thymoma classification: my opinion. Am. J. Clin. Pathol. 1999 112 304 307.
15. Suster S, Moran CA. Thymoma classification. The ride of the valkyries? Am. J. Clin. Pathol. 1999 112 308 310.
16. Müller-Hermelink H, Marino M, Palestro G. The human thymus. Pathology of thymic epithelial tumors. In Müller-Hermelink H ed. Current topics in pathology. Berlin: Springer-Verlag, 1986.
17. Müller-Hermelink HK, Marx A. Thymoma. Curr. Opin. Oncol. 2000 12 426 433.
18. Close PM, Kirchner T, Uys CJ, Müller-Hermelink HK. Reproducibility of a histogenetic classification of thymic epithelial tumours. Histopathology 1995 26 339 343.
19. Dawson A, Ibrahim NB, Gibbs AR. Observer variation in the histopathological classification of thymoma: correlation with prognosis. J. Clin. Pathol. 1994 47 519 523.
20. Chen G, Marx A, Wen-Hu C et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002 95 420 429.
21. Kornstein MJ, Curran WJ Jr., Turrisi AT 3rd., Brooks JJ et al. Cortical versus medullary thymomas: a useful morphologic distinction? Hum. Pathol. 1988 19 1335 1339.
22. Lardinois D, Rechsteiner R, Läng RH et al. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann. Thorac. Surg. 2000 69 1550 1555.
23. Pescarmona E, Rendina EA, Venuta F et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann. Thorac. Surg. 1990 50 534 538.
24. Pescarmona E, Rendina EA, Venuta F, Ricci C, Ruco LP, Baroni CD. The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases. Am. J. Clin. Pathol. 1990 93 190 195.
25. Quintanilla-Martinez L, Wilkins EW Jr., Choi N, Efird J, Hug E, Harris NL. Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 1994 74 606 617.
26. Pan CC, Wu HP, Yang CF, Chen WY, Chiang H. The clinicopathological correlation of epithelial subtyping in thymoma: a study of 112 consecutive cases. Hum. Pathol. 1994 25 893 899.
27. Rosai J, Sobin L. Histological typing of tumors of the thymus. World Health Organization. International histological classification of tumours. Heidelberg: Springer-Verlag, 1999.
28. Travis W et al., eds. Pathology and genetics of tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours. Lyon: IARC Press, 2004.
29. Ritter JH, Wick MR. Primary carcinomas of the thymus gland. Semin. Diagn. Pathol. 1999 16 18 31.
30. Dorfman DM, Shahsafaei A, Chan JK. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am. J. Surg. Pathol. 1997 21 936 940.
31. Nakagawa K, Matsuno Y, Kunitoh H, Maeshima A, Asamura H, Tsuchiya R. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest 2005 128 140 144.
32. Pomplun S, Wotherspoon AC, Shah G, Goldstraw P, Ladas G, Nicholson AG. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Histopathology 2002 40 152 158.
33. Hishima T, Fukayama M, Fujisawa M et al. CD5 expression in thymic carcinoma. Am. J. Pathol. 1994 145 268 275.
34. Nonaka D, Fukayama M, Fujisawa M. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms. Am. J. Surg. Pathol. 2007 31 1038 1044.
35. Kim DJ, Yang WI, Choi SS, Kim KD, Chung KY. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. Chest 2005 127 755 761.
36. Okumura M, Ohta M, Tateyama H et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002 94 624 632.
37. Rieker RJ, Hoegel J, Morresi-Hauf A et al. Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int. J. Cancer 2002 98 900 906.
38. Hiroshima K, Iyoda A, Toyozaki T et al. Proliferative activity and apoptosis in thymic epithelial neoplasms. Mod. Pathol. 2002 15 1326 1332.
39. Inoue M, Starostik P, Zettl A et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res. 2003 63 3708 3715.
40. Penzel R, Hoegel J, Schmitz W et al. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka. Int. J. Cancer 2003 105 494 498.
41. Zettl A, Ströbel P, Wagner K et al. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am. J. Pathol. 2000 157 257 266.
42. Zhou R, Zettl A, Ströbel P et al. Thymic epithelial tumors can develop along two different pathogenetic pathways. Am. J. Pathol. 2001 159 1853 1860.
43. Chalabreysse L, Roy P, Cordier JF, Loire R, Gamondes JP, Thivolet-Bejui F. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am. J. Surg. Pathol. 2002 26 1605 1611.
44. Sonobe S, Miyamoto H, Izumi H et al. Clinical usefulness of the WHO histological classification of thymoma. Ann. Thorac. Cardiovasc. Surg. 2005 11 367 373.
45. Park MS, Chung KY, Kim KD et al. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann. Thorac. Surg. 2004 78 992 997 discussion 997-998.
46. Rena O, Papalia E, Maggi G et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 2005 50 59 66.
47. Strobel P, Bauer A, Puppe B et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J. Clin. Oncol. 2004 22 1501 1509.
48. Suster S, Moran CA. Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am. J. Clin. Pathol. 1999 111 826 833.
49. Suster S. Diagnosis of thymoma. J. Clin. Pathol. 2006 59 1238 1244.
50. Suster S, Moran CA. Problem areas and inconsistencies in the WHO classification of thymoma. Semin. Diagn. Pathol. 2005 22 188 197.
51. Suster S, Moran CA. Thymoma classification: current status and future trends. Am. J. Clin. Pathol. 2006 125 542 554.